Novartis AG acquires Sabex Inc. for US$565 million

Client

Sabex Inc. and its shareholder RoundTable Healthcare Partners, a private investment fund located in Forest Lake, Illinois

Date

August 2004
On August 13, 2004, the Novartis AG subsidiary Novartis Pharmaceuticals Canada Inc. acquired all of Sabex Inc.'s shares for the consideration of $500 million in cash.

Sabex Inc. is a distributor and Canadian manufacturer of injectable generic pharmaceutical products for the hospital and retail markets.